Download Citation
Article Source:
Evaluation of the Validity of Preemptive Therapy against Cytomegalovirus Disease Based on Antigenemia Assay with a Cutoff of 20 Positive Cells per Two Slides
Sakamoto K,
Nakasone H,
Wada H,
Yamasaki R,
Ishihara Y,
et al.
(2013)
Evaluation of the Validity of Preemptive Therapy against Cytomegalovirus Disease Based on Antigenemia Assay with a Cutoff of 20 Positive Cells per Two Slides.
PLOS ONE 8(9): e73754.
https://doi.org/10.1371/journal.pone.0073754